This company listing is no longer active
BiVictriX Therapeutics Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
BiVictriX Therapeutics has a total shareholder equity of £2.3M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £3.0M and £676.0K respectively.
Belangrijke informatie
0%
Verhouding schuld/eigen vermogen
UK£0
Schuld
| Rente dekkingsratio | n/a |
| Contant | UK£1.69m |
| Aandelen | UK£2.31m |
| Totaal verplichtingen | UK£676.00k |
| Totaal activa | UK£2.98m |
Recente financiële gezondheidsupdates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: BVX's short term assets (£2.6M) exceed its short term liabilities (£589.0K).
Langlopende schulden: BVX's short term assets (£2.6M) exceed its long term liabilities (£87.0K).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: BVX is debt free.
Schuld verminderen: BVX had no debt 5 years ago.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: BVX has less than a year of cash runway based on its current free cash flow.
Voorspelling contante baan: BVX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 28% each year